Cerestim

Curated by Signal

Brain stimulation therapy for the treatment of brain disorders

Overview

Cerestim develops brain stimulation therapy for the treatment and management of disorders of the brain. They have develops a transcranial electrical stimulation technology will be initially targeted at the condition of treatment resistant depression. Ian Harris is the Director and CEO of the company.

Key facts

Founded: 2014
Headquarters: Cambridge, United Kingdom
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Healthcare Technology
Manufacturer of wearable health monitoring systems
Life Sciences TechnologyWaterlooville, United Kingdom
Transdermal Diagnostics
Provider of a needle-free continuous glucose monitoring device
Life Sciences TechnologyBath, United Kingdom
Microdot
Blood glucose meter
Life Sciences TechnologyGodmanchester, United Kingdom

About Cerestim

What does Cerestim do?

Cerestim develops brain stimulation therapy for the treatment and management of disorders of the brain.

Where is Cerestim headquartered?

Cerestim is headquartered in Cambridge, United Kingdom.

When was Cerestim founded?

Cerestim was founded in 2014.

Which sector is Cerestim in?

Cerestim operates in Life Sciences Technology.

Who are Cerestim's competitors?

Companies similar to Cerestim include Healthcare Technology, Transdermal Diagnostics, and Microdot.